Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-01-20 Sale |
2021-01-22 4:30 pm |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J See Remarks |
10,000 | $12.08 | $120,826 | 524,845 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-12-03 Option Award |
2020-12-07 4:30 pm |
N/A 2030-12-02 |
Fulcrum Therapeutics Inc. | FULC | Ezekowitz Alan Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2020-12-03 Option Award |
2020-12-07 4:30 pm |
N/A 2030-12-02 |
Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale SVP, General Counsel |
153,600 | $0 | 153,600 (Direct) |
View |
Ownership |
2020-12-07 4:15 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale SVP, General Counsel |
0 | $0 | 0 (Direct) |
View |
| 2020-09-14 Exercise |
2020-09-14 4:19 pm |
N/A 2029-01-21 |
Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer |
6,350 | $0 | 209,030 (Direct) |
View |
| 2020-09-14 Exercise |
2020-09-14 4:19 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer |
6,350 | $7.84 | 209,030 (Direct) |
View |